Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s last program in the process. IGM responded by laying off 80% of its staff and closing most of its lab and ...

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma refocuses its relationship with Innate Pharma from oncology to ...

Sanofi is racing to raise the flag on meningitis awareness—literally. The Paris-based pharma is fittingly symbolizing the “race against time” that is the fight against rapidly progressing ...

Sanofi has launched Dupixent for COPD in eight countries, said Hudson, who added that 2025 will be the "inflection year," for the treatment in the indication. Related ...

The Narne Nithiin, Sangeeth Sobhan, and Ram Nithin starrer Telugu action comedy film Mad Square has emerged as a successful outing at the box office. The movie is now inching towards an important ...

April 18 (Reuters) - The U.S. Food and Drug Administration approved the use of Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a ...

Investing.com -- Moody’s Ratings has upgraded the long-term issuer rating and senior unsecured ratings of Sanofi (NASDAQ:SNY) from A1 to Aa3. The outlook for the company has been revised from ...

Hello everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q1 2025 Conference Call for Investors and Analysts. As usual you can find the slides on sanofi.com. Please turn ...

The board of directors of Sanofi (NASDAQ:SNY) have proposed an annual dividend of €3.92 per share, an increase of 4.26% from prior dividend of €3.76 per share. Sanofi intends to execute a ...

Sanofi SNY reported first-quarter 2025 adjusted earnings of 94 cents per American depositary share, which beat the Zacks Consensus Estimate of 90 cents per share. Earnings of €1.79 per share ...

Speaking during a fireside chat at Swiss Biotech Day 2025, which took place 5–6 May in Basel, Houman Ashrafian, executive vice president and head of Research and Development (R&D) at Sanofi ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...